INTELLIGENCE IN ACTION

Reinventing the Health IT Adoption Curve: Price Transparency at the Point of Care

November 14, 2018

Good news on the health IT front: The Surescripts Network Alliance™ is serving the needs of both providers and patients by delivering prescription price transparency and patient-specific benefit information at the point of care. This breakthrough technology is available now, and it’s catching on at an impressive rate.

Since its launch last year, there has been a 40-fold increase in the number of prescribers who have used Real-Time Prescription Benefit—a total of 30 million times—to view patient-specific prescription price information, plus therapeutic alternatives, within their electronic health record (EHR).

The solution’s rapid rate of growth is driven by collaboration across the network with several EHR software vendors and pharmacy benefit managers (PBMs) adopting or going live with Real-Time Prescription Benefit in recent months.  

EHRs representing 77 percent of U.S. prescribers have already signed on, including Allscripts, Aprima Medical Software, Cerner, eClinicalWorks, Epic, Modernizing Medicine and NextGen Healthcare.

Real-Time Prescription Benefit provides patient benefit data directly from leading PBMs and health plans, including CVS Health, DST, which was acquired by SS&C Technologies, Express Scripts and Navitus, who collectively reach 70 percent of U.S. covered lives.

It’s simple: Easing the way for patients to pick up and begin their medications makes them more likely to adhere to their treatment plans. And improved medication adherence improves the quality, safety and cost of healthcare across the board.

Watch the video below to see how Real-Time Prescription Benefit is a breakthrough technology that solves a major healthcare challenge.


Read the latest press release to learn more about how Surescripts is improving the prescribing experience for thousands of providers and patients across the country.

Related Articles

March 15, 2019

HIMSS19 Highlights: Five Takeaways from Healthcare Leaders on Prescription Price Transparency

Judging by recent news headlines and my social media feed, this year’s HIMSS gathering seemed to be the most exciting and energized yet—not only because of the many emerging technologies under discussion and on display, but also the overall sense that the industry is making real progress, and positively impacting patient care in some very real ways. And the Surescripts Network Alliance™ led discussions throughout the show demonstrating this impact through the lens of a very hot topic: prescription price transparency.

Read more...
February 19, 2019

Disrupting the Drug Cost Trajectory: Dr. Michelle Mello on Making Medications Affordable

Prescription drug prices continue to rise, with no end in sight. Americans have complained to their representatives about the rising prices and policymakers are listening. A new Politico-Harvard poll of U.S. adults found that 80 percent of those surveyed said that lowering prescription drug prices should be an “extremely important” priority for the new Congress. Read more...
February 13, 2019

Prescribers and Patients are Working Together to Save Time, Money and Hassle

Prescription drugs comprise 17 percent of America's prescription drug spending, which is projected to grow by an average of 6.3 percent annually between 2017 and 2026. In fact, just one year from now, we are projected to spend $610-640B on medications alone. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX